Ziebart T, Pabst A, Klein MO, Kämmerer P, Gauss L, Brüllmann D, Al-Nawas B, Walter C

Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.

Clin Oral Investig, 15(1):105-11, 2011

Ziebart T, Walenta S, Kunkel M, Wagner W, Müller-Klieser W

Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.

J Cancer Clin Oncol, 137(2):193-9, 2011

Ziebart T, Koch F, Klein MO, Guth J, Adler J, Pabst A, Al-Nawas B, Walter C 

Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.   

Oral Oncol, 47(3):195-201, 2011

Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B

Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.

Oral Dis, 17(2):194-9, 2011

Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W

Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner -a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.  

J Craniomaxillofac Surg, 39(8):562-9, 2011

Koch FP, Wunsch A, Merkel C, Ziebart T, Pabst A, Yekta SS, Blessmann M, Smeets R

The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro.

Head Face Med, 7(1):4, 2011